Press Release – New York, NY – January 28, 2022 – Sichenzia Ross Ference LLP congratulates MAINZ BIOMED N.V. (the “Company”) (NASDAQ: MYNZ ), a molecular genetics diagnostic company specializing in …
Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to MAINZ BIOMED B.V. in $11.5 Million U.S. Initial Public Offering
Press Release – New York, NY – November 11, 2021 – Sichenzia Ross Ference LLP congratulates MAINZ BIOMED B.V. (the “Company”) (NASDAQ: MYNZ ), a molecular genetics diagnostic company specializing in …
Sichenzia Ross Ference LLP Represents Wunong Net Technology Company Limited in $30 Million Initial Public Offering
Press Release – New York, NY – December 17, 2020 – Sichenzia Ross Ference LLP announced today that it represented Wunong Net Technology Company Limited (Nasdaq: WNW) in a $30 million initial public …
Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering
Press Release – New York, NY – June 24, 2020 - Sichenzia Ross Ference LLP today announced that it represented Hudson Capital Inc. (NASDAQ: HUSN), in a $3.7 million registered direct offering of its …